Longhua Chinese medicine最新文献_第7页

Pharmacology of Chinese herbal medicine 中草药药理学

Longhua Chinese medicine Pub Date : 2021-01-01 DOI: 10.21037/lcm-22-2

Zhixiu Lin, Hong-Xi Xu, Lisa Xian

引用次数: 0

Discussion on traditional Chinese medicine and modern scientific research methodology 论中医学与现代科学研究方法

Longhua Chinese medicine Pub Date : 2021-01-01 DOI: 10.21037/lcm-21-54

Bohua Li, L. Despotova-Toleva

引用次数: 0

Traditional Chinese medicine, “Celastrol” and its nanotechnology for cancers: a narrative review 中药，“雷公藤红素”及其纳米技术治疗癌症:述评

Longhua Chinese medicine Pub Date : 2021-01-01 DOI: 10.21037/lcm-20-48

Siu Kan Law, Albert Wingnang Leung, Chuanshan Xu

{"title":"Traditional Chinese medicine, “Celastrol” and its nanotechnology for cancers: a narrative review","authors":"Siu Kan Law, Albert Wingnang Leung, Chuanshan Xu","doi":"10.21037/lcm-20-48","DOIUrl":"https://doi.org/10.21037/lcm-20-48","url":null,"abstract":": Nanotechnology is widely used in traditional Chinese medicine. The nanonization technology provides a platform for the development of molecular medicine such as detection and treatment of illnesses, body part replacement, regenerative medicine, nanoscale surgery, and targeted delivery of drugs. Nano Chinese medicine delivery system plays a significant role in the drug formulations, targeting area, and controlled its drug release. These can be utilized as delivery agents by encapsulating drugs, attaching therapeutic drugs, and delivering the drug to target tissues. Some of the bioactive natural compounds in traditional Chinese medicine such as celastrol have been incorporated with nanoparticles for curing diseases through enhancing bioavailability, targeting, and controlling its release, resulting in better therapeutic effects regarding the use of nanomaterials in drug delivery. There are several nanosystems for celastrol that have been reported also discussed the mechanism, and the toxicity of several types of celastrol nanoparticles. Its nano-system helps to increase solubility and stability, avoid toxicity, enhance pharmacological activity, improve tissue distribution, sustain delivery, and protect from physical or chemical degradation. Folic acid is the most common cancer targeting agent. This is water-soluble and delivers celastrol selectively to cancer cells only. Thus, nanotechnology of traditional Chinese medicine is attracting scientists’ attention.","PeriodicalId":74086,"journal":{"name":"Longhua Chinese medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44265335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Acupuncture treatment for patients with mild, moderate and severe Alzheimer’s disease 针灸治疗轻、中、重度阿尔茨海默病

Longhua Chinese medicine Pub Date : 2021-01-01 DOI: 10.21037/lcm-21-45

B. Ji, Guo-zhen Zhao, Bo Li, Yitian Liu, Nana Han, Yunpeng Ge, Yang Fang, Jingyu Zhang

引用次数: 0

Bioactive compounds from natural products with antidiabetic potentials 具有抗糖尿病潜能的天然产物的生物活性化合物

Longhua Chinese medicine Pub Date : 2021-01-01 DOI: 10.21037/lcm-21-64

L. S. Chua

引用次数: 0

A narrative review of giant cell arteritis in China 巨细胞动脉炎在中国的发展述评

Longhua Chinese medicine Pub Date : 2021-01-01 DOI: 10.21037/lcm-21-18

E. Ing, A. Xu, John Liu, F. Tyndel, A. Sundaram, W. Lam

{"title":"A narrative review of giant cell arteritis in China","authors":"E. Ing, A. Xu, John Liu, F. Tyndel, A. Sundaram, W. Lam","doi":"10.21037/lcm-21-18","DOIUrl":"https://doi.org/10.21037/lcm-21-18","url":null,"abstract":"Objective: To determine the incidence of giant cell arteritis (GCA) in China. Background: GCA is the most common primary vasculitis in the elderly and can cause bilateral irreversible blindness, aortitis, stroke and rarely death. The incidence of GCA in China is thought to be low, but has not been formally examined. Methods: A narrative review of the English language publications concerning GCA in China was performed on the PubMed and Google Scholar databases from inception to May 30, 2021. Conclusions: Five case series of GCA patients in China from Beijing, Changsha and Hong Kong showed the average number of GCA patients at the different hospitals varied from 1.7 to 9.6 patients per year. A retracted, outlier study from Lanzhou, China reported up to 336 patients per year. Latitude, smoking prevalence, percentage of Han Chinese ancestry, and average life expectancy in each city did not seem to influence the number of GCA patients. Excluding the outlier study, the incidence of GCA in China remains low. Overlap in the diagnosis of GCA with Takayasu arteritis may account for reports of higher relative incidence. To determine accurate incidence rates for GCA in China future studies require an accurate age-appropriate population denominator.","PeriodicalId":74086,"journal":{"name":"Longhua Chinese medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43974355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Probiotics in common urological conditions: a narrative review 常见泌尿系统疾病中的益生菌:叙述性回顾

Longhua Chinese medicine Pub Date : 2021-01-01 DOI: 10.21037/lcm-21-62

Sarita Das, Shaikh Ameeruddin

引用次数: 1

Effectiveness of electroacupuncture for a patient with a complete traumatic spinal cord injury: a case report 电针治疗完全性脊髓损伤1例疗效观察

Longhua Chinese medicine Pub Date : 2021-01-01 DOI: 10.21037/lcm-21-69

Joana Alcoba Kait, Emilio Estivill, Rosa Cabanas-Valdés

引用次数: 0

Narrative review: Chinese medicine against the COVID-19: current status, challenge and perspectives 叙述综述：中医药对抗新冠肺炎：现状、挑战和展望

Longhua Chinese medicine Pub Date : 2021-01-01 DOI: 10.21037/lcm-21-26

Juan Zhang, Wen Yang, Hong Xu, Yan-Fang Xian, Zhi-xiu Lin